Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Beyond Air Inc.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients (male and female) admitted to the hospital for clinical diagnosis of viral pneumonia including COVID-19 patients that have a positive nasal swab.
Age 18 to 80 years
Female subjects must be willing to use medically acceptable contraception from screening to Day 30 (acceptable forms of contraception: abstinence, hormonal birth control, intrauterine device, or barrier method plus a spermicidal agent).
Ability to understand and comply with study requirements.
Signed informed consent by subject
You may not be if
Patients with pneumonia with two or more of the following:
1. WBC of more than 15,000
2. Lobar pneumonia
3. Pleural effusion
Patients who are treated with or require high flow nasal cannula, CPAP, intubation, mechanical ventilation, or tracheostomy
Breastfeeding or pregnancy as evidenced by a positive pregnancy test.
Subjects diagnosed with immunodeficiency, with history of congestive or unstable heart disease, left ventricular dysfunction (LVEF \<40%) or myocardial damage, severe pulmonary hypertension and/or unstable hypertension
Use of an investigational drug during the last 30 days prior enrollment
Methemoglobin level \>3% at screening
Patients on chronic (over two weeks of treatment) systemic steroids (any formulation, excluding Dexamethasone or Prednisone) within 30 days prior to enrollment.
History of daily, continuous oxygen supplementation
Smokers who are unwilling to refrain from smoking during hospitalization
Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the subject or the quality of the data, e.g., known or suspected thalassemia, sickle cell disease or other diseases associated with poor oxygen carrying capacity.
The subject is identified by the investigator as being unable or unwilling to perform study procedures.
